GITNUXREPORT 2026

Aging Statistics

Aging is a biological decline across every system in the human body.

Sarah Mitchell

Senior Researcher specializing in consumer behavior and market trends.

First published: Feb 13, 2026

Our Commitment to Accuracy

Rigorous fact-checking · Reputable sources · Regular updatesLearn more

Statistic 1

Alzheimer's disease prevalence doubles every 5 years after 65, reaching 30% at 85.

Statistic 2

Cardiovascular disease mortality risk increases 2-fold per decade after 40.

Statistic 3

Type 2 diabetes incidence rises from 4% at 45-54 to 27% at 75+.

Statistic 4

Osteoporosis affects 50% of women over 50, with 20% fracture risk.

Statistic 5

Chronic kidney disease stage 3+ prevalence is 47% in 60+, vs 6% in 20-39.

Statistic 6

Cataract surgery rates peak at 70-79 with 80% needing by 80.

Statistic 7

Parkinson's disease incidence is 1% at 60, 4% at 80.

Statistic 8

COPD prevalence 10% in 65+, causing 80% of age-related lung deaths.

Statistic 9

Hearing loss affects 30% over 65, 50% over 75.

Statistic 10

Colorectal cancer risk triples after 65.

Statistic 11

Multimorbidity affects 65% of 65+, 82% of 80+.

Statistic 12

Frailty syndrome prevalence 10% at 65, 25% at 75.

Statistic 13

Sarcopenia affects 10% over 60, muscle mass loss >2%/year.

Statistic 14

Urinary incontinence 40% in women 65+.

Statistic 15

Glaucoma prevalence 2% at 40, 8% at 80.

Statistic 16

Rheumatoid arthritis remission rates drop 50% after 65.

Statistic 17

Macular degeneration 10% over 65, 30% over 75.

Statistic 18

Falls cause 3 million ER visits yearly in 65+, 30% with fractures.

Statistic 19

Pneumonia hospitalization 5x higher in 65+ vs young.

Statistic 20

Depression prevalence 7% in 60+, doubles with chronic disease.

Statistic 21

Dementia affects 10% over 65, 30% over 85.

Statistic 22

Atrial fibrillation prevalence 9% in 65+.

Statistic 23

Chronic obstructive pulmonary disease (COPD) mortality up 4-fold after 65.

Statistic 24

Prostate cancer 60% of cases in 65+.

Statistic 25

Hip fracture risk 20x higher after 80.

Statistic 26

Human telomeres shorten by an average of 25-50 base pairs per year in leukocytes, accelerating with oxidative stress.

Statistic 27

Somatic mutation accumulation in human cells increases exponentially after age 60, reaching over 10,000 mutations per cell by age 80.

Statistic 28

Mitochondrial DNA mutation load in post-mitotic tissues like muscle reaches 0.5-1% by age 70, impairing energy production.

Statistic 29

Epigenetic age acceleration measured by Horvath clock correlates with a 2.5-year mortality risk increase per 5-year acceleration.

Statistic 30

Protein homeostasis failure leads to aggregates like amyloid-beta increasing 10-fold from age 40 to 80 in brain tissue.

Statistic 31

NAD+ levels decline by 50% between ages 20 and 50 in human tissues, affecting sirtuin activity and DNA repair.

Statistic 32

Senescent cell burden doubles every decade after 60, secreting SASP factors that promote inflammation.

Statistic 33

Ribosomal RNA fragmentation increases 3-fold from young to old human fibroblasts, impairing translation fidelity.

Statistic 34

Histone acetylation decreases by 30-50% in aging human neurons, linked to cognitive decline.

Statistic 35

DNA methylation at clock CpG sites drifts by 1-3% per decade, predicting biological age.

Statistic 36

Glycation end-products accumulate at 1-2 mmol/mol collagen per decade in skin.

Statistic 37

MicroRNA-34a expression rises 4-fold in aging human hearts, promoting apoptosis.

Statistic 38

Autophagy flux declines by 40-60% in aging human muscle cells.

Statistic 39

Chromatin accessibility in promoters decreases by 20% from age 20 to 70 in blood cells.

Statistic 40

Proteasome activity drops 30% in human fibroblasts by passage 30, mimicking aging.

Statistic 41

RNA editing events increase 2-fold in aging human brain, altering splicing.

Statistic 42

Lamin B1 levels fall 50% in senescent human cells, destabilizing nuclear lamina.

Statistic 43

Heteroplasmy levels in mtDNA rise to 5-10% in aging oocytes.

Statistic 44

Glycolytic enzyme activity shifts 25% towards inefficiency in old human muscle.

Statistic 45

Non-coding RNA expression dysregulates 15% more in centenarian blood vs. young.

Statistic 46

Collagen cross-linking via AGEs increases tensile strength by 50% but reduces elasticity by 30% per decade.

Statistic 47

p16INK4a expression rises 7-fold in CD8 T cells from age 20 to 70.

Statistic 48

H3K27me3 marks spread ectopically 2-fold in aging human stem cells.

Statistic 49

tRNA modifications decrease 20% in old human liver, causing mistranslation.

Statistic 50

Nuclear pore complex assembly defects accumulate 3-fold in progeric cells.

Statistic 51

Sphingolipid ceramide levels rise 2-3 fold in aging human plasma.

Statistic 52

Inflammasome activation in macrophages increases NLRP3 by 40% post-60.

Statistic 53

Yamanaka factor expression partially reverses epigenetic age by 3.6 years in human cells.

Statistic 54

APOE4 carriers show 2x faster epigenetic aging in brain regions.

Statistic 55

rDNA copy number instability leads to 10% heterochromatin loss in old yeast models applicable to humans.

Statistic 56

Calorie restriction extends mouse lifespan 30-40%.

Statistic 57

Metformin reduces all-cause mortality 15% in diabetics.

Statistic 58

Senolytics like dasatinib+quercetin clear 30-60% senescent cells in mice.

Statistic 59

Rapamycin extends mouse lifespan 9-14% at low doses.

Statistic 60

NAD+ boosters like NR increase NAD 60% in humans.

Statistic 61

Exercise adds 3-7 years to life expectancy.

Statistic 62

Mediterranean diet correlates with 20% lower mortality.

Statistic 63

Yamanaka factors OSKM partial reprogramming extends mouse lifespan 30%.

Statistic 64

Glycine + NAC (GlyNAC) improves mitochondrial function 50% in old humans.

Statistic 65

Alpha-ketoglutarate extends worm lifespan 50%, mouse 12%.

Statistic 66

Hyperbaric oxygen therapy increases telomere length 20% in humans.

Statistic 67

Intermittent fasting improves insulin sensitivity 20-30%.

Statistic 68

Klotho overexpression doubles mouse lifespan.

Statistic 69

Fisetin senolytic reduces biomarkers 25% in humans phase 1.

Statistic 70

Human growth hormone + DHEA + metformin combo adds 2 years in pilot.

Statistic 71

Sleep 7-9 hours correlates with 10% lower mortality.

Statistic 72

Social connections add 50% longevity boost.

Statistic 73

CAR-T senolytic therapy clears 90% senescent cells in mice.

Statistic 74

Urolithin A improves muscle endurance 12% in old humans.

Statistic 75

Gene therapy for follistatin increases muscle 20% in primates.

Statistic 76

Parabiosis young blood plasma rejuvenates mouse tissues 50%.

Statistic 77

17-alpha estradiol extends male mouse lifespan 12%.

Statistic 78

Acarbose extends mouse lifespan 22% in females.

Statistic 79

Epithalon peptide extends telomere length 33% in humans pilot.

Statistic 80

Time-restricted eating 16:8 improves biomarkers 10-20%.

Statistic 81

Peak VO2 declines by 10% per decade after 30 in healthy adults, reflecting mitochondrial dysfunction.

Statistic 82

Bone mineral density decreases 1-2% annually post-menopause in women.

Statistic 83

Renal glomerular filtration rate drops 8-10 mL/min/1.73m² per decade after 40.

Statistic 84

Elastic arteries stiffen by 50% from age 20 to 80, raising systolic BP by 40 mmHg.

Statistic 85

Lean body mass decreases 3-8% per decade after 30, mostly muscle.

Statistic 86

Subcutaneous fat redistributes to visceral by 20-30% increase after 60.

Statistic 87

Lens elasticity reduces 80% by age 70, impairing accommodation.

Statistic 88

Pulmonary vital capacity declines 20-30 mL/year after 35.

Statistic 89

Taste bud regeneration slows to half speed after 60, reducing sensitivity.

Statistic 90

Salivary flow rate decreases 40% from age 20 to 80.

Statistic 91

Bladder capacity shrinks 20-30% by age 70.

Statistic 92

Corneal sensitivity drops 30% after 60.

Statistic 93

Hand grip strength peaks at 30-40, declines 1% yearly after 50.

Statistic 94

Walking speed slows 0.02 m/s per decade after 30.

Statistic 95

Lymphocyte proliferation response halves by age 70.

Statistic 96

DHEA-S levels fall 80-90% from age 25 to 75.

Statistic 97

Estrogen drops 90% post-menopause, accelerating bone loss.

Statistic 98

Testosterone declines 1-2% annually after 30 in men.

Statistic 99

Growth hormone secretion decreases 14% per decade after 20.

Statistic 100

Melatonin production falls 50% by age 60.

Statistic 101

Insulin sensitivity reduces 30% by age 70.

Statistic 102

Baroreflex sensitivity declines 50% from young to old.

Statistic 103

Pupil dilation response slows 40% after 50.

Statistic 104

Sweat gland output decreases 30% per decade after 40.

Statistic 105

Hair growth rate halves after 50.

Statistic 106

Wound healing time doubles after 60.

Statistic 107

World population 65+ projected to double from 10% to 16% by 2050.

Statistic 108

By 2050, 80% of older people will live in low/middle-income countries.

Statistic 109

Life expectancy at birth reached 73.3 years globally in 2020.

Statistic 110

US 65+ population to grow from 58M in 2022 to 82M by 2050.

Statistic 111

Japan has 29% population over 65 in 2023.

Statistic 112

Europe median age 43.9 years in 2023, up from 37 in 2000.

Statistic 113

India 65+ to rise from 6% to 13% by 2050.

Statistic 114

Number of centenarians worldwide projected 3.7M by 2050 from 573K in 2020.

Statistic 115

Female life expectancy exceeds males by 5 years globally.

Statistic 116

1 in 6 people globally 60+ by 2050.

Statistic 117

US baby boomers (born 1946-1964) number 73M, all 65+ by 2030.

Statistic 118

China 65+ population 190M in 2023, 28% by 2040.

Statistic 119

Dependency ratio (65+/working age) to rise 56% globally by 2100.

Statistic 120

Africa 60+ from 5% to 9% by 2050, despite youth bulge.

Statistic 121

Italy 24% over 65, highest in EU.

Statistic 122

Global old-age dependency ratio from 15% in 2020 to 25% by 2050.

Statistic 123

US nursing home residents 1.3M, 80% over 65.

Statistic 124

South Korea median age to hit 50 by 2040.

Statistic 125

Brazil 65+ from 10% to 25% by 2050.

Statistic 126

Russia life expectancy 73 years, but 65+ 16%.

Statistic 127

Global 80+ population triples to 426M by 2050.

Statistic 128

Healthy life expectancy lags life expectancy by 6 years globally.

Statistic 129

EU 65+ women outnumber men 2:1 due to longevity gap.

Statistic 130

Nigeria 65+ only 3%, but doubling by 2050.

Statistic 131

Singapore 65+ 15% in 2023, 25% by 2030.

Statistic 132

Older adults 50+ comprise 25% of US poverty risk.

Statistic 133

Global pension spending 7% of GDP, rising to 10% by 2050.

Statistic 134

15% of US 65+ live alone.

Statistic 135

Caregiving costs families $600B annually in US.

Statistic 136

Age discrimination in hiring reduces callbacks 40% for 64+.

Statistic 137

Social Security benefits replace 40% of pre-retirement income.

Statistic 138

Elder financial abuse costs $3B yearly in US.

Statistic 139

Retirement savings median $88K for 65-74 US households.

Statistic 140

50% of older adults forgo care due to cost.

Statistic 141

Long-term care costs average $100K/year in nursing homes.

Statistic 142

Workforce participation 65+ up 50% since 2000 in US.

Statistic 143

Digital divide: 42% of 65+ never use internet.

Statistic 144

Age-friendly cities initiative covers 1,000+ globally.

Statistic 145

Widowhood poverty rate 15% vs 5% for couples.

Statistic 146

Volunteerism among 65+ contributes $78B to US economy.

Statistic 147

Housing equity for 65+ averages $300K but illiquid.

Statistic 148

Medicare spending $800B in 2022, 21% of national health spend.

Statistic 149

Intergenerational wealth transfer $84T by 2045 in US.

Statistic 150

Rural older adults 20% more likely isolated.

Statistic 151

Gig economy participation 65+ tripled since 2010.

Statistic 152

Food insecurity 10% among 60+ low-income.

Statistic 153

Telehealth adoption 76% among 65+ post-COVID.

Statistic 154

Reverse mortgages used by 1% of 65+ homeowners.

Statistic 155

Grandparent caregiving 25% of 65+.

1/155

Sources

Trusted by 500+ publications

+497

From the relentless shortening of our telomeres to the profound decline of our cells’ repair mechanisms, every statistic presented here paints a detailed molecular picture of why we age and how it shapes our healthspan.

Key Takeaways

Human telomeres shorten by an average of 25-50 base pairs per year in leukocytes, accelerating with oxidative stress.
Somatic mutation accumulation in human cells increases exponentially after age 60, reaching over 10,000 mutations per cell by age 80.
Mitochondrial DNA mutation load in post-mitotic tissues like muscle reaches 0.5-1% by age 70, impairing energy production.
Peak VO2 declines by 10% per decade after 30 in healthy adults, reflecting mitochondrial dysfunction.
Bone mineral density decreases 1-2% annually post-menopause in women.
Renal glomerular filtration rate drops 8-10 mL/min/1.73m² per decade after 40.
Alzheimer's disease prevalence doubles every 5 years after 65, reaching 30% at 85.
Cardiovascular disease mortality risk increases 2-fold per decade after 40.
Type 2 diabetes incidence rises from 4% at 45-54 to 27% at 75+.
World population 65+ projected to double from 10% to 16% by 2050.
By 2050, 80% of older people will live in low/middle-income countries.
Life expectancy at birth reached 73.3 years globally in 2020.
Older adults 50+ comprise 25% of US poverty risk.
Global pension spending 7% of GDP, rising to 10% by 2050.
15% of US 65+ live alone.

Aging is a biological decline across every system in the human body.

Age-Related Diseases

Alzheimer's disease prevalence doubles every 5 years after 65, reaching 30% at 85.
Cardiovascular disease mortality risk increases 2-fold per decade after 40.
Type 2 diabetes incidence rises from 4% at 45-54 to 27% at 75+.
Osteoporosis affects 50% of women over 50, with 20% fracture risk.
Chronic kidney disease stage 3+ prevalence is 47% in 60+, vs 6% in 20-39.
Cataract surgery rates peak at 70-79 with 80% needing by 80.
Parkinson's disease incidence is 1% at 60, 4% at 80.
COPD prevalence 10% in 65+, causing 80% of age-related lung deaths.
Hearing loss affects 30% over 65, 50% over 75.
Colorectal cancer risk triples after 65.
Multimorbidity affects 65% of 65+, 82% of 80+.
Frailty syndrome prevalence 10% at 65, 25% at 75.
Sarcopenia affects 10% over 60, muscle mass loss >2%/year.
Urinary incontinence 40% in women 65+.
Glaucoma prevalence 2% at 40, 8% at 80.
Rheumatoid arthritis remission rates drop 50% after 65.
Macular degeneration 10% over 65, 30% over 75.
Falls cause 3 million ER visits yearly in 65+, 30% with fractures.
Pneumonia hospitalization 5x higher in 65+ vs young.
Depression prevalence 7% in 60+, doubles with chronic disease.
Dementia affects 10% over 65, 30% over 85.
Atrial fibrillation prevalence 9% in 65+.
Chronic obstructive pulmonary disease (COPD) mortality up 4-fold after 65.
Prostate cancer 60% of cases in 65+.
Hip fracture risk 20x higher after 80.

Age-Related Diseases Interpretation

The body is a cruel and comically busy architect of its own decline, where each passing birthday gift-wraps a fresh statistical likelihood of some new system deciding to stage a mutiny.

Cellular and Molecular Aging

Human telomeres shorten by an average of 25-50 base pairs per year in leukocytes, accelerating with oxidative stress.
Somatic mutation accumulation in human cells increases exponentially after age 60, reaching over 10,000 mutations per cell by age 80.
Mitochondrial DNA mutation load in post-mitotic tissues like muscle reaches 0.5-1% by age 70, impairing energy production.
Epigenetic age acceleration measured by Horvath clock correlates with a 2.5-year mortality risk increase per 5-year acceleration.
Protein homeostasis failure leads to aggregates like amyloid-beta increasing 10-fold from age 40 to 80 in brain tissue.
NAD+ levels decline by 50% between ages 20 and 50 in human tissues, affecting sirtuin activity and DNA repair.
Senescent cell burden doubles every decade after 60, secreting SASP factors that promote inflammation.
Ribosomal RNA fragmentation increases 3-fold from young to old human fibroblasts, impairing translation fidelity.
Histone acetylation decreases by 30-50% in aging human neurons, linked to cognitive decline.
DNA methylation at clock CpG sites drifts by 1-3% per decade, predicting biological age.
Glycation end-products accumulate at 1-2 mmol/mol collagen per decade in skin.
MicroRNA-34a expression rises 4-fold in aging human hearts, promoting apoptosis.
Autophagy flux declines by 40-60% in aging human muscle cells.
Chromatin accessibility in promoters decreases by 20% from age 20 to 70 in blood cells.
Proteasome activity drops 30% in human fibroblasts by passage 30, mimicking aging.
RNA editing events increase 2-fold in aging human brain, altering splicing.
Lamin B1 levels fall 50% in senescent human cells, destabilizing nuclear lamina.
Heteroplasmy levels in mtDNA rise to 5-10% in aging oocytes.
Glycolytic enzyme activity shifts 25% towards inefficiency in old human muscle.
Non-coding RNA expression dysregulates 15% more in centenarian blood vs. young.
Collagen cross-linking via AGEs increases tensile strength by 50% but reduces elasticity by 30% per decade.
p16INK4a expression rises 7-fold in CD8 T cells from age 20 to 70.
H3K27me3 marks spread ectopically 2-fold in aging human stem cells.
tRNA modifications decrease 20% in old human liver, causing mistranslation.
Nuclear pore complex assembly defects accumulate 3-fold in progeric cells.
Sphingolipid ceramide levels rise 2-3 fold in aging human plasma.
Inflammasome activation in macrophages increases NLRP3 by 40% post-60.
Yamanaka factor expression partially reverses epigenetic age by 3.6 years in human cells.
APOE4 carriers show 2x faster epigenetic aging in brain regions.
rDNA copy number instability leads to 10% heterochromatin loss in old yeast models applicable to humans.

Cellular and Molecular Aging Interpretation

It’s like your cells are a beautifully detailed book, but by the final chapters the ink is fading, the pages are brittle, the spine is creaking, and some madman keeps scribbling in the margins with a permanent marker.

Longevity and Interventions

Calorie restriction extends mouse lifespan 30-40%.
Metformin reduces all-cause mortality 15% in diabetics.
Senolytics like dasatinib+quercetin clear 30-60% senescent cells in mice.
Rapamycin extends mouse lifespan 9-14% at low doses.
NAD+ boosters like NR increase NAD 60% in humans.
Exercise adds 3-7 years to life expectancy.
Mediterranean diet correlates with 20% lower mortality.
Yamanaka factors OSKM partial reprogramming extends mouse lifespan 30%.
Glycine + NAC (GlyNAC) improves mitochondrial function 50% in old humans.
Alpha-ketoglutarate extends worm lifespan 50%, mouse 12%.
Hyperbaric oxygen therapy increases telomere length 20% in humans.
Intermittent fasting improves insulin sensitivity 20-30%.
Klotho overexpression doubles mouse lifespan.
Fisetin senolytic reduces biomarkers 25% in humans phase 1.
Human growth hormone + DHEA + metformin combo adds 2 years in pilot.
Sleep 7-9 hours correlates with 10% lower mortality.
Social connections add 50% longevity boost.
CAR-T senolytic therapy clears 90% senescent cells in mice.
Urolithin A improves muscle endurance 12% in old humans.
Gene therapy for follistatin increases muscle 20% in primates.
Parabiosis young blood plasma rejuvenates mouse tissues 50%.
17-alpha estradiol extends male mouse lifespan 12%.
Acarbose extends mouse lifespan 22% in females.
Epithalon peptide extends telomere length 33% in humans pilot.
Time-restricted eating 16:8 improves biomarkers 10-20%.

Longevity and Interventions Interpretation

We're trying to outwit the grim reaper with a toolkit that ranges from eating less and moving more, to wiping out zombie cells and tinkering with our very genes, yet the most powerful elixir still seems to be a good meal with friends.

Physiological Changes

Peak VO2 declines by 10% per decade after 30 in healthy adults, reflecting mitochondrial dysfunction.
Bone mineral density decreases 1-2% annually post-menopause in women.
Renal glomerular filtration rate drops 8-10 mL/min/1.73m² per decade after 40.
Elastic arteries stiffen by 50% from age 20 to 80, raising systolic BP by 40 mmHg.
Lean body mass decreases 3-8% per decade after 30, mostly muscle.
Subcutaneous fat redistributes to visceral by 20-30% increase after 60.
Lens elasticity reduces 80% by age 70, impairing accommodation.
Pulmonary vital capacity declines 20-30 mL/year after 35.
Taste bud regeneration slows to half speed after 60, reducing sensitivity.
Salivary flow rate decreases 40% from age 20 to 80.
Bladder capacity shrinks 20-30% by age 70.
Corneal sensitivity drops 30% after 60.
Hand grip strength peaks at 30-40, declines 1% yearly after 50.
Walking speed slows 0.02 m/s per decade after 30.
Lymphocyte proliferation response halves by age 70.
DHEA-S levels fall 80-90% from age 25 to 75.
Estrogen drops 90% post-menopause, accelerating bone loss.
Testosterone declines 1-2% annually after 30 in men.
Growth hormone secretion decreases 14% per decade after 20.
Melatonin production falls 50% by age 60.
Insulin sensitivity reduces 30% by age 70.
Baroreflex sensitivity declines 50% from young to old.
Pupil dilation response slows 40% after 50.
Sweat gland output decreases 30% per decade after 40.
Hair growth rate halves after 50.
Wound healing time doubles after 60.

Physiological Changes Interpretation

Nature meticulously dismantles our body part by part, like a grimly efficient landlord gutting a once-vibrant apartment, leaving us with a mortgage of maintenance and a creeping suspicion that the best parts of the warranty have expired.

Population Aging

World population 65+ projected to double from 10% to 16% by 2050.
By 2050, 80% of older people will live in low/middle-income countries.
Life expectancy at birth reached 73.3 years globally in 2020.
US 65+ population to grow from 58M in 2022 to 82M by 2050.
Japan has 29% population over 65 in 2023.
Europe median age 43.9 years in 2023, up from 37 in 2000.
India 65+ to rise from 6% to 13% by 2050.
Number of centenarians worldwide projected 3.7M by 2050 from 573K in 2020.
Female life expectancy exceeds males by 5 years globally.
1 in 6 people globally 60+ by 2050.
US baby boomers (born 1946-1964) number 73M, all 65+ by 2030.
China 65+ population 190M in 2023, 28% by 2040.
Dependency ratio (65+/working age) to rise 56% globally by 2100.
Africa 60+ from 5% to 9% by 2050, despite youth bulge.
Italy 24% over 65, highest in EU.
Global old-age dependency ratio from 15% in 2020 to 25% by 2050.
US nursing home residents 1.3M, 80% over 65.
South Korea median age to hit 50 by 2040.
Brazil 65+ from 10% to 25% by 2050.
Russia life expectancy 73 years, but 65+ 16%.
Global 80+ population triples to 426M by 2050.
Healthy life expectancy lags life expectancy by 6 years globally.
EU 65+ women outnumber men 2:1 due to longevity gap.
Nigeria 65+ only 3%, but doubling by 2050.
Singapore 65+ 15% in 2023, 25% by 2030.

Population Aging Interpretation

The world is getting a fantastic facelift, but it’s time to seriously stock the shelves and reinforce the swing sets before we're a planet of spry centenarians watching their grandkids try to fund our pensions.

Socioeconomic Factors

Older adults 50+ comprise 25% of US poverty risk.
Global pension spending 7% of GDP, rising to 10% by 2050.
15% of US 65+ live alone.
Caregiving costs families $600B annually in US.
Age discrimination in hiring reduces callbacks 40% for 64+.
Social Security benefits replace 40% of pre-retirement income.
Elder financial abuse costs $3B yearly in US.
Retirement savings median $88K for 65-74 US households.
50% of older adults forgo care due to cost.
Long-term care costs average $100K/year in nursing homes.
Workforce participation 65+ up 50% since 2000 in US.
Digital divide: 42% of 65+ never use internet.
Age-friendly cities initiative covers 1,000+ globally.
Widowhood poverty rate 15% vs 5% for couples.
Volunteerism among 65+ contributes $78B to US economy.
Housing equity for 65+ averages $300K but illiquid.
Medicare spending $800B in 2022, 21% of national health spend.
Intergenerational wealth transfer $84T by 2045 in US.
Rural older adults 20% more likely isolated.
Gig economy participation 65+ tripled since 2010.
Food insecurity 10% among 60+ low-income.
Telehealth adoption 76% among 65+ post-COVID.
Reverse mortgages used by 1% of 65+ homeowners.
Grandparent caregiving 25% of 65+.

Socioeconomic Factors Interpretation

The statistics reveal that our later years are a precarious mix of solitude, systemic gaps, and staggering financial strain, painting a future where aging with dignity often feels more like a luxury than a guarantee.

Sources & References

Logos provided by Logo.dev